Singapore: Israel-based Oramed Pharmaceuticals, a developer of oral drug delivery systems, has announced receiving two a...
Singapore: Novo Nordisk announced that the Japanese Ministry of Health, Labour and Welfare has approved Ryzodeg (insu...
Singapore: Japanese company Mitsubishi Tanabe Pharma and Canada-based Cytochroma have terminated a license agreement exe...
When the Indian generic sector forayed into the global arena almost two decades back, the affordability of its treatment...
Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, ...
Singapore: ReproCELL, a Japanese stem cell technology company, has opened the company's first branch and US office in Bo...
Singapore: Japanese pharmaceutical company Kyowa Hakko Kirin temporarily suspended patient enrollment in an internationa...
Singapore: "BIOtech 2013 in Japan", which recorded significant growth both in the scale and the quality, concluded in hu...
Singapore: A large-scale retrospective database analysis on atorvastatin (Lipitor) by Astellas Pharma and Pfizer Japan h...
Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a glo...
Singapore: The Indian Department of Commerce is showcasing the achievement of the country's pharmaceutical sector at the...
Singapore: In order to speed up the approval process for medical devices, Japan is planning to introduce some changes in...
Singapore: The Jikei University School of Medicine has become the second Japanese university to find that clinical data ...
Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protei...
Singapore: Dr Takeshi Yura has been promoted by AMRI to the position of vice president of discovery and development serv...
Singapore: A new study by Reports and Reports predicted that the stem cell therapy market in Asia Pacific (APAC) will gr...
Singapore: Medtronic started Symplicity HTN-Japan, the first clinical trial with the Symplicity renal denervation system...
Singapore: Bristol-Myers Squibb and Pfizer announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has...
